Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL)

被引:1
|
作者
Ciccone, Maria [1 ]
Vitale, Candida [1 ]
Hinojosa, Christina [1 ]
Keating, Michael J. [1 ]
Pemmaraju, Naveen [1 ]
O'Brien, Susan [1 ]
Burger, Jan A. [1 ]
Thomas, Deborah A. [1 ]
Kantarjian, Hagop M. [1 ]
Strati, Paolo [1 ]
Wierda, William G. [1 ]
Ferrajoli, Alessandra [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1182/blood.V124.21.5656.5656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Consolidation Treatment with Lenalidomide Following Front-line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
    Strati, Paolo
    Keating, Michael
    Burger, Jan
    O'Brien, Susan
    Wierda, William
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S299 - S300
  • [42] Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia
    Strati, Paolo
    Keating, Michael J.
    Burger, Jan A.
    O'Brien, Susan M.
    Wierda, William G.
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    HAEMATOLOGICA, 2017, 102 (12) : 494 - 496
  • [43] Consolidation Treatment with Lenalidomide Following Front-line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia
    Strati, Paolo
    Keating, Michael J.
    Burger, Jan A.
    O'Brien, Susan M.
    Wierda, William G.
    Estrov, Zeev
    Zacharian, Gracy
    Ferrajoli, Alessandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S12 - S13
  • [44] A Multicenter, Phase IV Observational Study Of Ofatumumab In Chronic Lymphocytic Leukemia (CLL): A European Research Initiative On CLL (ERIC) Study
    Moreno, Carol
    Montillo, Marco
    Panayiotis, Panayiotidis
    Bloor, Adrian
    Dupuis, Jehan
    Schuh, Anna
    Norin, Stefan
    Geisler, Christian H.
    Hillmen, Peter
    Doubek, Michael
    Obrtlikova, Petra
    Laurenti, Luca
    Stilgenbauer, Stephan
    Smolej, Lukas
    Ghia, Paolo
    Cymbalista, Florence
    Jaeger, Ulrich
    Stavroyianni, Niki
    Carrington, Patrick
    Zouabi, Hamadi
    Leblond, Veronique
    Carlos Gomez, Juan
    Marasca, Roberto
    Musuraca, Gerardo
    Rigacci, Luigi
    Farina, Lucia
    Paolini, Rossella
    Pospisilova, Sarka
    Kimby, Eva
    Bradley, Colm
    Montserrat, Emili
    BLOOD, 2013, 122 (21)
  • [45] Phase I/II study of rituxan in chronic lymphocytic leukemia (CLL).
    O'Brien, S
    Freireich, E
    Andreeff, M
    Lerner, S
    Keating, M
    BLOOD, 1998, 92 (10) : 105A - 105A
  • [46] Phase II trial of theophylline for early stage chronic lymphocytic leukemia (CLL).
    Makower, D
    Lee, S
    Wiernik, PH
    Paietta, E
    Bennett, JM
    Wade, J
    Ghosh, C
    Kaminer, L
    Tallman, MS
    BLOOD, 2001, 98 (11) : 290B - 290B
  • [47] What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Benjamin N. Voorhies
    Deborah M. Stephens
    Current Treatment Options in Oncology, 2017, 18
  • [48] What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Voorhies, Benjamin N.
    Stephens, Deborah M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (02)
  • [49] UPDATED RESULTS OF A PHASE 3 RANDOMIZED, CONTROLLED STUDY OF IDELALISIB IN COMBINATION WITH OFATUMUMAB FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Robak, T.
    Jones, J.
    Wach, M.
    Brown, J.
    Menter, A.
    Vandenberghe, E.
    Ysebaert, L.
    Wagner-Johnston, N.
    Polikoff, J.
    Awan, F.
    Badoux, X.
    Coutre, S.
    Spurgeon, S.
    Loscertales, J.
    Xing, G.
    Dubowy, R.
    Flinn, I.
    Owen, C.
    HAEMATOLOGICA, 2016, 101 : 53 - 53
  • [50] Updated results of a phase III randomized, controlled study of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).
    Jones, Jeffrey Alan
    Robak, Tadeusz
    Wach, Malgorzata
    Brown, Jennifer R.
    Menter, Alexander R.
    Vandenberghe, Elizabeth
    Ysebaert, Loic
    Wagner-Johnston, Nina D.
    Polikoff, Jonathan
    Awan, Farrukh Tauseef
    Badoux, Xavier Camille Albert
    Coutre, Steven
    Spurgeon, Stephen Edward Forbes
    Loscertales, Javier
    Dreiling, Lyndah
    Xing, Guan
    Peterman, Sissy
    Dubowy, Ronald L.
    Flinn, Ian
    Owen, Carolyn
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)